Skip to content
Open access

Refining the Genetic Contribution to Type 2 Diabetes Subtypes

Jul 2026 · Diabetes, obesity and metabolism · Vol 28, pp. 9450 - 9460 · 0 citations · 53 references
Medicine

TL;DR

Heterogeneous genetic architectures across clinically defined T2D subtypes in a Middle Eastern population are found, providing evidence supporting differential polygenic burden, subtype genetic associations and subtype‐associated biological pathways across T2D subtypes.

Abstract

ABSTRACT Background Type 2 diabetes (T2D) is a complex and highly heterogeneous disease driven in part by genetic predisposition and can be stratified into clinical subgroups to aid disease management. We recently grouped T2D subjects in the Qatar Biobank (QBB) cohort into Severe Insulin‐Deficient Diabetes (SIDD), Severe Insulin‐Resistant Diabetes (SIRD), Mild Obesity‐Related Diabetes (MOD) and Mild Age‐Related Diabetes (MARD) subtypes. Herein, we focused on the genetic makeup of these subtypes. Methods We used the QBB cohort (n = 13,808), of whom 2687 were with T2D, and comprehensively assessed polygenic risk scores (PGS) across T2D subtypes, investigated genetic loci associated with each subtype by leveraging the most recent and largest GWAS for T2D, evaluated SNP associations across T2D genetic clusters, and identified protein interaction pathways associated with these distinct T2D subtypes. Results MOD showed consistently lower PGS compared with other T2D subtypes across all tested scores. SIDD showed more associations with SNPs mapping to residual glycemic cluster compared with other T2D subtypes. The incremental analysis of PGS004838 demonstrated a high ΔAUC of 0.101 for SIDD and a moderate ΔAUC of 0.068 for SIRD, but not for MOD and MARD. Protein interaction analyses identified candidate subtype‐associated gene networks linked to pathways related to glucose homeostasis in SIDD, insulin signalling and hepatic metabolism in SIRD, body fat distribution in MOD and vascular‐related processes in MARD. Conclusion We found heterogeneous genetic architectures across clinically defined T2D subtypes in a Middle Eastern population. Our findings provide evidence supporting differential polygenic burden, subtype genetic associations and subtype‐associated biological pathways across T2D subtypes. These observations support the utility of subtype‐based genetic analyses for improving biological understanding of T2D heterogeneity.

Read PDF

Similar papers

Open access Sep 2026

Novel type 1 diabetes polygenic scores improve identification of type 1 diabetes in diverse populations

Most polygenic scores (PS) for type 1 diabetes were developed using European (EUR) ancestry datasets, limiting performance in non-European (non-EUR) populations. We evaluated novel type 1 diabetes PS across diverse populations to assess whether newer models improve prediction in underrepresented populations. Seven type...

Stella Nam, R. Kreienkamp, Jiang Li et al. · 0 citations
Sep 2026

Genome-Wide Association Analyses Identify Distinct Genetic Architectures for Extreme Early-Onset and Late-Onset T2D.

Extreme AAO-defined T2D subtypes exhibit partially distinct genetic architectures, highlighting AAO as an important dimension of T2D heterogeneity and providing a framework for future age-stratified genetic risk assessment.

Ben Niu, Ming-Hui Xia, Jia-Xin Wu et al. · 0 citations
Sep 2026

Shared non-HLA genetic architecture across diverse ancestries links insulin secretion and resistance to type 1 diabetes.

The findings support the existence of a shared non-HLA genetic architecture that may link type 1 diabetes susceptibility to both impaired insulin secretion and insulin resistance, providing preliminary genetic evidence for their convergent pathogenic mechanisms.

Qi Fu, Ke-Yao Wang, Min Shen et al. · 0 citations
Open access Sep 2026

Decomposing population differences in type 2 diabetes through a high-resolution GWAS of ~600,000 individuals with East Asian ancestry

Type 2 diabetes (T2D) is a highly heterogeneous metabolic trait, with a higher prevalence in East Asians. Despite extensive genetic studies focusing mainly on Europeans, how genetic risk for T2D is distributed across biological pathways in East Asians in comparison with Europeans remains incompletely understood. Here,...

Kohei Saito, Hsing-Fang Lu, Tatsuhide Inoue et al. · 0 citations
Open access Sep 2026

Genetic and Clinical Determinants of Variation in Drug Response in Type 2 Diabetes: Insights From the Scottish and UK Biobank Cohorts

The contributions of clinical characteristics and genetic predisposition as measured through partitioned polygenic risk scores (pPRS) to variation in glycemic response to glucose‐lowering therapies are quantified.

S. Garg, R. Kitchen, R. Gupta et al. · 0 citations
Open access Aug 2026

Proteomic Pathways Linking Type 2 Diabetes Genetic Clusters to Cardiovascular Diseases: A Network Mendelian Randomisation Study

This network Mendelian randomisation study delineates protein-mediated pathways linking cluster-stratified T2D genetic predisposition to cardiovascular risk, which can inform preventive strategies by stratifying individuals based on distinct biological pathways represented by these genetic clusters.

Shuang Liao, Gabriel Chun Yin Sung, Yiwen Liang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.